Search Results - "Blijlevens, Nicole N M"

Low relapse risk in poor risk AML after conditioning with 10-day decitabine, fludarabine and 2 Gray TBI prior to allogeneic hematopoietic cell transplantation by Cruijsen, Marjan, Hilberink, Jacobien R., van der Velden, Walter J. F. M., Jansen, Joop H., Bär, Brigitte, Schaap, Nicolaas P. M., de Haan, Anton, Mulder, André B., de Groot, Marco R., Baron, Frédéric, Vellenga, Edo, Blijlevens, Nicole N. M., Huls, Gerwin

“…Patients with poor risk acute myeloid leukemia (AML) have a dismal outcome. We hypothesized that combining decitabine with a standard non-myeloablative (NMA)…”
Get full text

Long-Term Analysis of Resilience of the Oral Microbiome in Allogeneic Stem Cell Transplant Recipients by Laheij, Alexa M G A, Rozema, Frederik R, Brennan, Michael T, von Bültzingslöwen, Inger, van Leeuwen, Stephanie J M, Potting, Carin, Huysmans, Marie-Charlotte D N J M, Hazenberg, Mette D, Brandt, Bernd W, Zaura, Egija, Buijs, Mark J, de Soet, Johannes J, Blijlevens, Nicole N M, Raber-Durlacher, Judith E

“…Stem cell transplantation (SCT) is associated with oral microbial dysbiosis. However, long-term longitudinal data are lacking. Therefore, this study aimed to…”
Get full text

Addition of 10-Day Decitabine to Fludarabine/Total Body Irradiation Conditioning is Feasible and Induces Tumor-Associated Antigen-Specific T Cell Responses by Cruijsen, Marjan, Hobo, Willemijn, van der Velden, Walter J.F.M, Bremmers, Manita E.J, Woestenenk, Rob, Bär, Brigitte, Falkenburg, J.H. Frederik, Kester, Michel, Schaap, Nicolaas P.M, Jansen, Joop, Blijlevens, Nicole N.M, Dolstra, Harry, Huls, Gerwin

“…Abstract Allogeneic hematopoietic cell transplantation (HCT) offers the possibility of curative therapy for patients with myelodysplastic syndromes (MDS),…”
Get full text